Journal article
Feasibility and reproducibility of neurochemical profile quantification in the human hippocampus at 3 T
- Abstract:
- Hippocampal dysfunction is known to be associated with several neurological and neuropsychiatric disorders such as Alzheimer's disease, epilepsy, schizophrenia and depression; therefore, there has been significant clinical interest in studying hippocampal neurochemistry. However, the hippocampus is a challenging region to study using (1) H MRS, hence the use of MRS for clinical research in this region has been limited. Our goal was therefore to investigate the feasibility of obtaining high-quality hippocampal spectra that allow reliable quantification of a neurochemical profile and to establish inter-session reproducibility of hippocampal MRS, including reproducibility of voxel placement, spectral quality and neurochemical concentrations. Ten healthy volunteers were scanned in two consecutive sessions using a standard clinical 3 T MR scanner. Neurochemical profiles were obtained with a short-echo (T(E) = 28 ms) semi-LASER localization sequence from a relatively small (~4 mL) voxel that covered about 62% of the hippocampal volume as calculated from segmentation of T1 -weighted images. Voxel composition was highly reproducible between sessions, with test-retest coefficients of variation (CVs) of 3.5% and 7.5% for gray and white matter volume fraction, respectively. Excellent signal-to-noise ratio (~54 based on the N-acetylaspartate (NAA) methyl peak in non-apodized spectra) and linewidths (~9 Hz for water) were achieved reproducibly in all subjects. The spectral quality allowed quantification of NAA, total choline, total creatine, myo-inositol and glutamate with high scan-rescan reproducibility (CV ≤ 6%) and quantification precision (Cramér-Rao lower bound, CRLB < 9%). Four other metabolites, including glutathione and glucose, were quantified with scan-rescan CV below 20%. Therefore, the highly optimized, short-echo semi-LASER sequence together with FASTMAP shimming substantially improved the reproducibility and number of quantifiable metabolites relative to prior reports. In addition, the between-session variation in metabolite concentrations, as well as CRLB, was lower than the between-subject variation of the concentrations for most metabolites, indicating that the method has the sensitivity to detect inter-individual differences in the healthy brain.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 645.3KB, Terms of use)
-
- Publisher copy:
- 10.1002/nbm.3309
Authors
- Publisher:
- Wiley
- Journal:
- NMR in biomedicine More from this journal
- Volume:
- 28
- Issue:
- 6
- Pages:
- 685-693
- Publication date:
- 2015-05-12
- Acceptance date:
- 2015-03-23
- DOI:
- EISSN:
-
1099-1492
- ISSN:
-
0952-3480
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:519614
- UUID:
-
uuid:9fee6113-a2c3-4b35-bafc-a904104ad4d9
- Local pid:
-
pubs:519614
- Source identifiers:
-
519614
- Deposit date:
-
2016-07-06
Terms of use
- Copyright holder:
- John Wiley & Sons, Ltd
- Copyright date:
- 2015
- Notes:
- This is the peer reviewed version of the following article: "Feasibility and reproducibility of neurochemical profile quantification in the human hippocampus at 3 T", which has been published in final form at 10.1002/nbm.3309. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
If you are the owner of this record, you can report an update to it here: Report update to this record